Prepare for a permanent crisis, Lotte's Shin Dong-bin warns

이재림 2023. 1. 12. 19:35
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

Lotte Group Chairman Shin Dong-bin said that Lotte will uphold company values by enhancing global competitiveness and continuing to push the company to challenge itself at a biannual value creation meeting Thursday. “The contemporary era is one of...
Lotte Group Chairman Shin Dong-bin pays his tribute to Lotte founder Shin Kyuk-ho at Lotte World Tower in eastern Seoul, Thursday. [LOTTE]

Lotte Group Chairman Shin Dong-bin said that Lotte will uphold company values by enhancing global competitiveness and continuing to push the company to challenge itself at a biannual value creation meeting Thursday.

“The contemporary era is one of permanent crisis,” Shin said, referring to continuing economic slowdown consisting of inflation, high interest rates and the strong dollar. “It’s totally different from a decade ago, when company management was secure.”

The value creation meeting is held to discuss the performance of group companies, analyze the business environment and examine the economic outlook. Some 70 employees gathered at the Lotte World Tower in southern Seoul.

The meeting was the first offline meeting held in three years since January 2020 due to Covid-19 pandemic.

Before the meeting took place, Shin and the CEOs paid their respects to the statue of Lotte founder Shin Kyuk-ho as a tribute to commemorate the third year of his death, which was Jan. 19, 2020.

Shin noted that in order for the group to gain global competitiveness, sustainable growth and profit was the key.

The Thursday meeting was attended by heads of the four Lotte business units: retail, hotel and services, chemicals and food.

Shin asked the CEOs to “regard the crisis as an opportunity to go forward.”

Referring to Lotte’s purchase of Bristol Myers Squibb’s bio plant and Iljin Materials, a copper foil maker, Shin asked the CEOs to be “bold” when it comes to investment, which is thought to be a must for the group to achieve its vision.

Lotte Biologics purchased Bristol Myers Squibb’s bio plant in Syracuse, New York for $160 million last May. Lotte Chemical acquired a 53.3 percent stake in Iljin Materials for 2.7 trillion won, .

“This year is an important period for the group as we have to prove our effort that we’ve prepared for the last several years, so that we can finally rebound,” said Shin. “If we do not challenge ourselves to change and innovate, the future will not be that much different from the past.”

BY LEE JAE-LIM [lee.jaelim@joongang.co.kr]

Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.

이 기사에 대해 어떻게 생각하시나요?